Editorial Policies

Aims and Scope

The journal discusses the most pressing health issues such as reproductive health protection, problems of modern perinatal obstetrics, and adverse effects of environmental and industrial factors on the women's reproductive system and health. The journal deposits new and important information and recommendations for practitioners (introduction of modern technologies, the use of effective drugs and diagnostic techniques, etc.). Of great interest are publications related to clinical genetics and the role of genetic factors in obstetric and gynecological pathology, medical and genetic counseling of patients with reproductive dysfunction and at the birth of children with congenital malformations and hereditary diseases in the past.

National reproductive behavior is a cause of the deteriorating health of the population, low fertility and the lack of simple reproduction of the population in this country. In this regard, there are regular publications of clinical and sociological studies on modern contraceptives in family planning, prevention of abortions and their harmful consequences for women's health. Publications related to perinatal protection of the fetus and newborn, timely identification of risk factors in pregnant women, and differentiated management, considering the pathology of pregnancy and extragenital diseases, as well as the choice of a rational method of delivery in all fairness occupy a large place in the journal.

Multifaceted coverage of the problems of reconstructive surgical gynecology remains traditional for the journal. These are improving the technique of surgical interventions, in particular, endoscopic methods using lasers, electro- and cryosurgery, as well as reconstructive plastic surgery of the pelvic floor using modern synthetic materials, prevention of tumor recurrence, medical rehabilitation, and therapeutic and rehabilitation therapy (improving the quality of life, restoring the ability to work, returning the ability to implement reproductive function). As before, the journal pays much attention to vaginal dysbiotic conditions, bacterial vaginosis, diagnosis and treatment of reproductive tract infections in pregnant women and gynecological patients. Taking into account the importance of the physiology and pathology of the perimenopause, due to the absolute and relative increase in the number of elderly and senile women, the journal systematically publishes materials on hormone replacement therapy.

The periodicity of the journal is six issues a year. In addition, special issues are published within the framework of congresses and conferences.

It can be stated with confidence that the first Russian "Journal of Obstetrics and Women's Diseases" makes a prominent contribution to the formation of the national school of obstetricians and gynecologists, and now supports and promotes promising scientific research, contributing to its implementation in practice and thus bringing valuable assistance to both doctors and patients.

 

Sections

Reviews

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Original Research

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Actual Health Care Problems

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Theory and Practice

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Public Health Organization

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Lectures

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Environment and woman reproduction health

Checked Open Submissions Checked Indexed Checked Peer Reviewed

History of medicine

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Information

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Viewpoint

Checked Open Submissions Checked Indexed Checked Peer Reviewed
 

Peer Review Process


A double-blind peer review method is mandatory for processing of all scientific manuscripts submitted to the editorial stuff of “Journal of Obstetrics and Woman Diseases”. This implies that neither the reviewer is aware of the authorship of the manuscript, nor the author maintains any contact with the reviewer.

  • Members of the editorial board and leading Russian and international experts in corresponding areas of life sciences, invited as independent readers, perform peer reviews. Editor-in-chief, Deputy Editor-in-chief or Science editor choose readers for peer review. We aim to limit the review process to 2-4 weeks, though in some cases the schedule may be adjusted at the reviewer´s request.
  • Reviewer has an option to abnegate the assessment should any conflict of interests arise that may affect perception or interpretation of the manuscript. Upon the scrutiny, the reviewer is expected to present the editorial board with one of the following recommendations: to accept the paper in its present state; to invited the author to revise their manuscript to address specific concerns before final decision is reached; that final decision be reached following further reviewing by another specialist; to reject the manuscript outright.
  • If the reviewer has recommended any refinements, the editorial staff would suggest the author either to implement the corrections, or to dispute them reasonably. Authors are kindly required to limit their revision to 2 months and resubmit the adapted manuscript within this period for final evaluation.
  • We politely request that the editor be notified verbally or in writing should the author decide to refuse from publishing the manuscript. In case the author fails to do so within 3 months since receiving a copy of the initial review, the editorial board takes the manuscript off the register and notifies the author accordingly.
  • If author and reviewers meet insoluble contradictions regarding revision of the manuscript, the editor-in-chief resolves the conflict by his own authority.
  • The editorial board reaches final decision to reject a manuscript on the hearing according to reviewers recommendations, and duly notifies the authors of their decision via e-mail. The board does not accept previously rejected manuscripts for re-evaluation.
  • Upon the decision to accept the manuscript for publishing, the editorial staff notifies the authors of the scheduled date of publication.
  • Kindly note that positive review does not guarantee the acceptance, as final decision in all cases lies with the editorial board. By his authority, editor-in-chief rules final solution of every conflict.
  • Original reviews of submitted manuscripts remain deposited permanently (not less than 5 years).
  • Manuscript reviews are not published. Reviews can be sent to the Ministry of Education and Sciense of Russian Federation in case of query.

 

Publication Frequency

Bimounthly publication. Articles are published in accordance with the rules for authors. Possible publication in the journal within conference proceedings, special issues and applications. Edition of 1000 copies.

 

Author Self-Archiving

This journal does not permits authors to post items submitted to the journal on personal websites or institutional repositories.

 

Issue Purchase

Readers without a subscription may still purchase individual issues. The following payment options and fees are available.

Access for an Issue: 35.00 (USD)

You can purchase the access for all articles published in one issue. Access to articles will be provide for an unlimited time.

Access to issue allows you to read, download and print full text (PDF and HTML) of all articles, but does not allow to distribute, copy or reproduce articles materials until the end of the embargo period (3 years) since the publication of the article).

 

Article Purchase

Readers without a subscription may still purchase individual articles. The following payment options and fees are available.

Access for an Article: 5.00 (USD)

You can purchase the access for the article to read, download and print its fulltext (PDF, HTML). Access to article will be provide for an unlimited time.

Purchased access does not allow to distribute, copy or reproduce article's materials until the end of the embargo period (3 years) since the publication of the article).

 

Archiving

The journal uses the PKP Preservation Network (PKP PN) to digitally preserve all the published articles. The PKP PN is a part of LOCKSS (Lots of Copies Keep Stuff Safe) program offers decentralized and distributed preservation, seamless perpetual access, and preservation of the authentic original version of the content.

Also, the journal makes full-text archives on the Russian Science Electronic Library (http://elibrary.ru/) platform.

 

Indexing

The journal is indexed in the following international databases and directory editions:

  • SCOPUS
  • Russian Science Citation Index - external module of the Web of Science
  • Google Scholar
  • Ulrich's Periodicals Directory
  • WorldCat

 

Publishing Ethics

The Ethic policy of the Journal is based on recommendations from international committees:

Reporting Standards

Authors of reports of original research should present an accurate account of the work performed as well as an objective discussion of its significance. Underlying data should be represented accurately in the manuscript. The manuscript should contain sufficient detail and references to permit others to replicate the work. Fraudulent or knowingly inaccurate statements constitute unethical behavior and are unacceptable.

Review and professional publication should also be accurate and objective, and editorial opinion works should be clearly identified as such.

Authors should use inclusive language that acknowledges diversity, conveys respect to all people, is sensitive to differences, and promotes equal opportunities. Manuscripts should make no assumptions about the beliefs or commitments of any reader, should contain nothing that might imply that one individual is superior to another on the grounds of race, sex, culture, or any other characteristic, and should use inclusive language throughout. Authors should ensure that writing is free from bias, for instance by using “he or she” and “his or her” or the gender-neutral pronouns “they, their”, and by making use of job titles that are free of stereotyping (e.g. “chairperson” instead of “chairman” and “flight attendant” instead of “stewardess”).

Authors should list all funding sources in the Acknowledgments section. Authors are responsible for the accuracy of their funder designation. If in doubt, please check the Open Funder Registry for the correct nomenclature.

Authors should adhere to:

  • instructions for submitting the manuscript to the Journal;
  • instructions contained in the e-mails received and the time frames indicated therein;
  • proofreading instructions.

The Publisher will consider any departure from these instructions as unethical behavior. Notification of this will be sent to the Editor-in-Chief.

Data Access and Retention

Authors may be asked to provide the raw data in connection with a paper for editorial review and should be prepared to provide public access to such data (consistent with the ALPSP-STM Statement on Data and Databases), if practicable, and should in any event be prepared to retain such data for a reasonable time after publication.

Authorship Clarified

The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out before the work is submitted.

The Publisher does not prescribe the kinds of contributions that warrant authorship. It is recommended that authors adhere to the guidelines for authorship that are applicable in their specific research field. In absence of specific guidelines it is recommended to adhere to the following guidelines (based on ICMJE guidelines):

The Editorial Board assumes that, all authors whose names appear on the submission:

  • made substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data; or the creation of new software used in the work AND
  • drafted the work or revised it critically for important intellectual content AND
  • approved the version to be published AND
  • agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Anyone who contributed to the research or manuscript preparation, but is not an author, should be acknowledged with their permission.

Submissions by anyone other than one of the authors will not be considered.

Originality and Plagiarism

Plagiarism takes many forms, from passing off another paper as the author(s) own paper, to copying or paraphrasing substantial parts of another(s) paper (without attribution), to claiming results from research conducted by others. Plagiarism in all its forms constitutes unethical publishing behavior and is unacceptable.

Only original works are acceptable for publication in the Journal. The Journal does not allow any forms of plagiarism.

If the authors have used the work and/or words of others, this should be appropriately cited or quoted.

The Journal is using "ANTIPLAGIAT" software for plagiarism detection in all manuscripts. Papers will be rejected from any stage of the publication process (even if the paper was published already) if plagiarism was detected.

Multiple, Redundant or Concurrent Publication

An author should not in general publish manuscripts describing essentially the same research in more than one journal or primary publication. Submitting the same manuscript to more than one journal concurrently constitutes unethical publishing behavior and is unacceptable.

In general, an author should not submit for consideration in another journal a previously published paper. Publication of some kinds of papers (e.g., clinical guidelines, translations) in more than one journal is sometimes justifiable, provided certain conditions are met. The authors and editors of the journals concerned must agree to the secondary publication, which must reflect the same data and interpretation of the primary document. The primary reference must be cited in the secondary publication. Further detail on acceptable forms of secondary publication can be found at http://www.icmje.org/

Acknowledgement of Sources

Proper acknowledgment of the work of others must always be given. Authors should cite publications that have been influential in determining the nature of the reported work. Information obtained privately, as in conversation, correspondence, or discussion with third parties, must not be used or reported without explicit, written permission from the source. Information obtained in the course of confidential services, such as refereeing manuscripts or grant applications, must not be used without the explicit written permission of the author of the work involved in these services.

Hazards and Human or Animal Subjects

If the work involves chemicals, procedures or equipment that have any unusual hazards inherent in their use, the author must clearly identify these in the manuscript. If the work involves the use of animal or human subjects, the author should ensure that the manuscript contains a statement that all procedures were performed in compliance with relevant laws and institutional guidelines and that the appropriate institutional committee(s) have approved them.

Research Ethics and Patient Consent (Statement of Human and Animal Rights)

When reporting experiments on human subjects (e.g. case study/report), authors should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 and 2008. If doubt exists whether the research was conducted in accordance with the Helsinki Declaration, the authors must explain the rationale for their approach, and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study.

When reporting experiments on animals, authors should be asked to indicate whether the institutional and national guide for the care and use of laboratory animals was followed.

Authors should include a statement in the manuscript that informed consent (written or verbal) was obtained for experimentation with human subjects. The privacy rights of human subjects must always be observed.

Research Involving Human Embryos, Gametes, and Stem Cells

Manuscripts that report experiments involving the use of human embryos and gametes, human embryonic stem cells and related materials, and clinical applications of stem cells must include confirmation that all experiments were performed in accordance with relevant guidelines and regulations.

The manuscript should include an ethics statement identifying the institutional and/or national research ethics committee (including the name of the ethics committee) approving the experiments and describing any relevant details. Authors should confirm that informed consent was obtained from all recipients and/or donors of cells or tissues, where necessary, and describe the conditions of donation of materials for research, such as human embryos or gametes. Copies of approval and redacted consent documents may be requested by the Journal.

We encourage authors to follow the principles laid out in the 2016 ISSCR Guidelines for Stem Cell Research and Clinical Translation.

In deciding whether to publish papers describing modifications of the human germline, the Journal is guided by safety considerations, compliance with applicable regulations, as well as the status of the societal debate on the implications of such modifications for future generations. In case of concerns regarding a particular type of study the Journal may seek the advice from the Springer Nature Research Integrity Group.

Disclosure and Conflicts of Interest

All authors should disclose in their manuscript any financial or other substantive conflict of interest that might be construed to influence the results or interpretation of their manuscript. All sources of financial support for the project should be disclosed.

Examples of potential conflicts of interest which should be disclosed include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Potential conflicts of interest should be disclosed at the earliest stage possible.
You may use Disclosure of interest form to complete the section of the paper.

Corrections, Retractions, and Editorial Expressions of Concern Policies

The Journal is committed to uphold the integrity of the literature and publishes Errata (Corrections), Expressions of Concerns or Retraction Notices dependent on the situation and in accordance with the COPE Retraction Guidelines. In all cases, these notices are linked to the original paper.

When an author discovers a significant error or inaccuracy in his/her own published work, it is the author’s obligation to promptly notify the Journal editor or publisher and cooperate with the editor to retract or correct the paper.

If the editor or the publisher learn from a third party that a published work contains a significant error, it is the obligation of the author to promptly retract or correct the paper or provide evidence to the editor of the correctness of the original paper.

When errors are identified in published papers, the publisher will consider what action is required and may consult the editors and the authors’ institution(s).

Errors by the authors may be corrected by a corrigendum, and errors by the publisher — by an erratum (see more).

If there are errors that significantly affect the conclusions or there is evidence of misconduct, this may require retraction or an expression of concern following the COPE Retraction Guidelines. All authors will be asked to agree to the content of the appropriate notice.

According to the rules of the Council on Ethics of Scientific Publications of Association of Science Editors and Publishers, the grounds for paper retraction are:

  • detection of plagiarism in the paper;
  • detection of falsifications (for example, manipulation of experimental data);
  • detection of serious errors that cast doubt on scientific value of the paper;
  • incorrect list of authors;
  • duplication of the paper in several journals;
  • republishing the paper without the author’s consent;
  • concealment of conflict of interest and other violations of publication ethics;
  • the fact that the paper has not been peer-reviewed.

After the decision to retract the paper is made, the Editor-in-Chief informs its authors, indicating the reason and date of retraction. The paper remains on the Journal’s site as part of the corresponding Journal issue but is marked “retracted” with the retraction date (the mark is placed on top of the text of the paper and in the table of contents). In addition, a message about retraction is placed in the news section of the site, and the Editor-in-Chief sends information about the paper retraction to all online libraries and databases in which the Journal is indexed.

Information on COPE Retraction Guidelines can be found here: Retraction Guidelines

More details can be observed on the Eco-Vector CrossMark Policy page: http://doi.org/10.17816/crossmarkpolicy2018

The Procedure of Retraction of the Paper

  • Authors, readers, reviewers, editors, and the Publisher can initiate a retraction of an paper by application to the editorial office of the Journal.
  • The Retraction Commission reviews the received application and notifies the interested parties about the beginning of the retraction procedure.
  • The Retraction Commission decides to retract the published paper if there are sufficient facts in favor of retraction.
  • The Retraction Commission notifies the initiator of the retraction of the paper about the results of consideration in written form.
  • If the commission decides to retract the paper, the Journal publishes information that the paper has been retracted, including the metadata of the retracted paper.
  • If papers from the Journal are indexed by any databases, a letter is sent to these databases stating that this paper has been retracted, indicating the reasons for retraction.
  • The editorial board has the right to independently decide on additional sanctions – for example, on the inclusion of authors in the blacklist of the Journal for a certain period, or indefinitely.

Principles of Professional Ethics of the Editorial Board and Publisher

The decision to publish a paper is the responsibility of the Editor-in-Chief of the Journal.

Editors’ responsibility
  • The editors of the Journal are personally responsible for deciding whether to publish.
  • When making decisions about publication, the editor can consult with other editors and reviewers.
  • The editor evaluates the content of the manuscripts without collecting information about the race, gender, sexual orientation, religious beliefs, origin, citizenship, or political preferences of the authors.
  • The editor and the Editorial Board do not unnecessarily disclose information about the manuscript in question to other persons, except for the authors, reviewers, possible reviewers, other scientific consultants, and the Publisher.
  • Editors recuse themselves from consideration of manuscripts in the event of conflicts of interest due to competitive, joint, or other interactions and relationships with the authors, companies and, possibly, other institutions associated with the manuscript.
  • The editor, together with the Publisher, will take appropriate action in the event of ethical claims regarding reviewed manuscripts or published papers. Such measures in general include interaction with the authors of the manuscript and the reasoning of the corresponding complaint or demand but can also imply interaction with relevant institutions and research centers whose interests may be affected.
Reviewer responsibility
  • Any reviewer selected by the editor who feels insufficiently qualified to review the manuscript or does not have enough time to quickly complete the work, notifies the editor and requests that he or she be excluded from the review of the corresponding manuscript.
  • Reviewers do not participate in the review of manuscripts in the event of conflicts of interest due to competitive, joint, or other interactions and relationships with any of the authors, companies or other institutions associated with the submitted work.
  • Reviewers inform the editor about the discovery of significant similarity or coincidence between the manuscript in question and any other published work that is in the field of scientific competence of the reviewer.
  • Reviewers do not use unpublished data obtained from submitted manuscripts for personal research without the written consent of the author.
  • Reviewers keep confidential and do not use information or ideas obtained during the review for personal gain.
  • Reviewers do not discuss the manuscript with anyone not authorized by the editor.
  • Reviewers consider personal criticism of the author unacceptable and try to give an objective assessment of the manuscript.
Copy editor responsibility

When working with manuscripts accepted for publication, the copy editor relies on the existing lexical and grammatical norms set out in the appropriate dictionaries, monographs, and manuals.

Layout editor responsibility

When preparing proofreading of an paper, the layout editor is guided by the standards adopted by the Publisher, based on the current state standards and international publishing practices.

The page is based on original materials from the Elsevier: http://cdn.elsevier.com/promis_misc/ethicalguidelinesforauthors.pdf

 

Publication Fee

Publication in "Journal of obstetrics and woman disease" journal is free for all authors.

The "Journal of obstetrics and woman disease" journal charge no publication fees for authors - including those of peer-review management, manuscript processing, journal production, Open-Access, online hosting and archiving.

 

Adverticement and reprint policy

Our advertising policy is consistent with the principles mentioned in the Recommendations on Publication Ethics Policies for Medical Journals which issued by the World Association of Medical Editors (WAME).

http://www.wame.org/recommendations-on-publication-ethics-policie

  1. The Eco-Vector’s journals generate revenue from advertising, which creates a potential conflict of interest. Editors’ decisions do not depend on the cost of advertising or producing reprints. Advertisers and sponsors have no influence over the editor’s decisions, regardless of the terms of advertising or other agreements.
  2. All advertisements are subject to the approval of the Eco-Vector’s staff, which reserves the right to reject or cancel any advertisement at any time.
  3. The functions of editors and advertising managers in Eco-Vector’s journals are separate.
  4. In Eco-Vector’s journals professional (physician-directed) publications and web sites, the intentional placement of advertising adjacent to articles discussing the company or product that is the subject of the advertisement is prohibited. Advertising content must be distinguished from editorial and other materials so that the difference between them is obvious.
  5. Eco-Vector will not publish “advertorial” content, and sponsored supplements must be clearly indicated as such. If a supplement did not undergo peer review or underwent a peer review-process different from the rest of the journal that should be explicitly stated.
  6. All Eco-Vector’s journals have the right to refuse any advertisement that, in its sole discretion, is incompatible with its mission or inconsistent with the values of members, the publication/web site or the organization as a whole, and to stop accepting any advertisement previously accepted. Advertisements are subject to review by the editors and others at the Eco-Vector’s journals. In no case shall separate agreements with Eco-Vector’s journals or its subsidiaries supersede this policy.
  7. Once an advertisement has been deployed online, it will be withdrawn from the journal site at any time if the Editor(s)-in-Chief or Eco-Vector’s staff request its removal.
  8. Advertising for the following categories is prohibited:
    • Alcohol
    • Tobacco
    • Weapons, firearms, ammunition
    • Fireworks
    • Gambling and lottery
    • Pornography or related themes
    • Political and religious advertisements
    • Advertisements that claim to have a “miracle” cure or method
    • Advertisements that make unsubstantiated health claims for the products advertised
    • Advertisements directed at children
  9. Advertisements may not be deceptive or misleading, and must be verifiable. Advertisements should clearly identify the advertiser and the product or service being offered. Exaggerated or extravagantly worded copy will not be allowed. Advertisements will not be accepted if they appear to be indecent or offensive in either text or artwork, or if they relate to content of a personal, racial, ethnic, sexual orientation, or religious nature.
  10. All advertisements are accepted and published by Eco-Vector on the warranty of the advertisement agency and advertiser that both are authorized to publish the entire contents and subject matter of the advertisement.
  11. In consideration of publication of an advertisement, the advertiser and the advertisement agency, jointly and severally, agree to indemnify and hold harmless Eco-Vector, its officers, agents and employees against expenses (including legal fees) and losses resulting from the publication of the contents of the advertisement, including, without limitation, claims or suits for libel, violation of privacy, copyright infringement, or plagiarism.
  12. Any references to Eco-Vector or its products or services in advertisements, promotional material, or merchandising by the advertiser or agency is subject to Eco-Vector’s written approval for such use.
  13. All advertisements for drug-specific campaigns must comply with the relevant Russian legislation that regulates advertising. Advertisers should make available to Eco-Vector the marketing authorization and summary of product characteristics when submitting their advertisement. In the case of drug advertisements, proprietary names of pharmaceutical products must be accompanied by the chemical, generic, or official name; the quantity of all active substances must be stated along with the recommended dosage. Each page of an advertisement for a prescription-only medicine should be clearly labeled as intended for health professionals.
  14. Advertisements for products not approved by the FDA or the Ministry of Health of Russian Federation that make any kind of health claims must carry the following disclaimer: “These statements have not been evaluated by the Food and Drug Administration and/or the Ministry of Health of Russian Federation. This product is not intended to diagnose, treat, cure or prevent any disease.”
  15. While Eco-Vector’s journals welcomes and encourages information-rich advertising, advertisements, advertising icons and advertiser logos must be clearly distinguishable from editorial content and may require special labeling to distinguish them as such. All advertisements must clearly and prominently identify the advertiser by trademark or signature.
  16. Reprints should be published only in the form in which they were originally published in the journal (including subsequent corrections), so there should be no additions or changes in them.
  17. Publisher is not responsible for incidental or consequential damage for errors in displaying or printing an advertisement.
  18. Advertisements may not imply endorsement by the Eco-Vector’s journals or its publications/web sites except as may be provided for under a separate agreement — in which case advertising must be pre-approved to ensure adherence to the letter and spirit of that separate agreement.
  19. The full rules for any market research or promotion associated with an advertisement must be displayed in the advertisement or available via a prominent link.
  20. The following online advertising formats are prohibited:
    • Pop-ups and floating advertisements.
    • Advertisements that collect personally identifiable information from visitors without their knowledge or permission.
    • Advertisements that extend across or down the page without the visitor having clicked or rolled-over the advertisement.
    • Advertisements that send visitors to another site without the visitor having clicked the advertisement.

Eco-Vector’s journals published advertising policies are not exhaustive and are subject to change at any time without notice.

We partner with third-party advertising companies to serve ads and/or collect certain information when you visit our website. These companies may use cookies or web beacons to collect non-personally identifiable information [not including your name, address, email address or telephone number] during your visit to this website to help show advertisements on other websites also likely to be of interest to you.

For contact with the Advertisement department of the Publisher, please, follow the link https://eco-vector.com/


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies